Condition
Vein Thrombosis
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting1
Unknown1
Not Yet Recruiting1
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07538609Not ApplicableNot Yet Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
NCT05409976Not ApplicableActive Not Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05489588Not ApplicableRecruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
NCT03202238Not ApplicableUnknown
TenTaTorch: Venepuncture Made Easy
NCT02407717Completed
Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer
Showing all 5 trials